|
DOSAGE
|
1gtt BID. Clinically, 1gtt qAM is common.
|
|
GENERIC
|
Timolol maleate 0.5% | Betimol (timolol hemihydrate 0.25%, 0.5%) - different chemical structure | Istalol (timolol maleate 0.5%) - dosed qAM | Timoptic Ocudose (timolol maleate 0.25%, 0.5%) - ocudose dispenser | Timoptic XE (timolol maleate 0.25, 0.5%) - gel forming solution
|
|
INDICATIONS
|
Reduces intraocular pressure (IOP)
|
|
MECHANISM OF ACTION
|
non-selective beta-adrenergic antagonist
|
|
MICROBIOLOGY
|
The predominant mechanism of ocular hypotensive action of topical beta-adrenergic blocking agents is likely due to a reduction in aqueous humor production.
|
|
CONTRAINDICATIONS & WARNINGS
|
Patients with overt heart failure, cardiogenic shock, sinus bradycardia, second- or third-degree atrioventricular block, bronchial asthma or history of bronchial asthma, or severe chronic obstructive pulmonary disease, or hypersensitivity to any component of this product.
|
|
PEDIATRIC USE
|
Safety and efficacy in pediatric patients have not been established.
|
